Close
ACHEMA MIDDLE EAST 2026
LogiPharma 2026

Drug Development

      Market For Oligonucleotides Forecast To Hit $16.7bn By 2027

      Clinical Trials
      The growth in ongoing clinical trials for oligonucleotide-based therapies in important therapeutic fields like oncology is expected to cause the global oligonucleotide synthesis market...

      New Decoy Medication Neutralises COVID-19 And Variations

      News
      Dana-Farber scientists have developed a medication that neutralises SARS-CoV-2, the COVID-19 coronavirus, and every other tested version. The medicine is developed so that natural...

      Addressing Cholestatic Liver Disease Upon Cognitive Decline

      News
      Cholestatic Bile flow can be hampered by liver conditions like primary biliary cholangitis (PBC), which can result in neurological problems. There is presently no known...

      Q3 Market Capitalization Declines For Top Biopharma Firms

      Drug Development
      The market capitalization of the top 20 biopharmaceutical businesses worldwide has decreased by 9.1%, from $3.45 trillion in Q2 2022 to $3.14 trillion in...

      EMA Urges The Withdrawal of Pholcodine Drugs From EU Market

      Drug Development
      PRAC, EMA's safety committee, has completed its review of pholcodine-containing medications used to treat nonproductive (dry) cough in adults and children as well as...

      Launch of The First Pipeline Assessment By Vaccines Europe

      Drug Development
      With 100 vaccine candidates as of July 2022, Vaccines Europe has released its first pipeline evaluation of the 15 firms that make up its...

      Non-Vaccine mRNA Therapeutics To Earn $2 Billion By 2028

      News
      A recent analysis from GlobalData estimates that by 2028, the approval of pipeline drugs will earn over $2 billion from five marketed messenger RNA...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

      System

      Resources

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.